Parasoft announced a partnership with Auriga, enabling Auriga clients to achieve reduced time-to-market by leveraging Parasoft’s automated software testing tool suite, ensuring quality at each stage of the SDLC. Parasoft and Auriga focus on helping organizations scale their test automation practice, with tools for static analysis and unit testing for Java, C/C++, and .NET development; application security testing; IoT-focused API testing; and service virtualization.
In today’s competitive landscape, organizations face immense pressure to deliver high-quality software quickly, and at a lower cost. This partnership brings together Parasoft’s automated testing solutions with Auriga’s consulting services, helping customers successfully face today’s most strategic development initiatives ─ such as safety-critical testing, continuous testing, Agile/DevOps, and security.
Organizations developing medical device software rely on static analysis from Parasoft and partners like Auriga to make FDA approval possible, including simply interpreting the requirements from the FDA, which can itself be extremely challenging. As the FDA adds more cybersecurity requirements in their new software validation guidance, medical device manufacturers require effective adoption and usage of static analysis, which is the most effective way to address safety and security concerns and deliver predictable software.